Article
1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness.
Molecular endocrinology (Baltimore, Md.) - 1 Sept 2005
Liu Wei, Asa Sylvia L, Ezzat Shereen
Abstract excerpt
We have previously reported that the hormonal form of 1alpha,25-dihydroxyvitamin D3 (1,25-VD3), and its noncalciomimetic analog EB1089, arrest the growth of human thyroid cancer cells by increasing the cell cycle inhibitor p27. In the present study, we investigated whether the tumor-suppressive effects of vitamin D (VD) compounds may also be mediated by mechanisms that govern cell adhesiveness. Both 1,25-VD3 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
